Estradiol-Progesterone Balance Paradigm: Heavy Menstrual Flow

Menorrhagia is the medical word for extremely heavy or protracted menstrual flow. This sort of abnormal uterine bleeding affects a large number of women. It can be caused by many different types of disorders, such as uterine abnormalities, hormonal issues, or other issues. If an egg is not fertilised during the menstrual cycle, the uterine lining breaks down and leaks. During this period, the egg and uterine lining are lost. Heavy bleeding can be caused by hormonal imbalances (e.g. oestrogen and progesterone, or other hormones) or uterine disorders (e.g. polyps, fibroids, adenomyosis, malignancy, etc.). Similar content being viewed by others

Andersch, B., Milsom, I., & Rybo, G. (1988). An objective evaluation of flurbiprofen and tranexamic acid in the treatment of idiopathic menorrhagia. Acta Obstetricia et Gynecologica Scandinavica, 67(7), 645–648. Andersson, K., Odlind, V., & Rybo, G. (1994). Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: A randomized comparative trial. Contraception, 49(1), 56–72. Benagiano, G., & Primiero, F. M. (2003). Seventy-five microgram desogestrel minipill, a new perspective in estrogen-free contraception. Annals New York Academy of Science, 997, 163–173. Bergeron, C., Amant, F., & Ferenczy, A. (2006). Pathology and physiopathology of adenomyosis. Best Practice & Research. Clinical Obstetrics & Gynaecology, 20(4), 511–521. Blaustein, J. D., & Wade, G. N. (1976). Ovarian influences on the meal patterns of female rats. Physiology & Behavior, 17, 201–208. Bofill Rodriguez, M., Lethaby, A., & Farquhar, C. (2019). Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database of Systematic Reviews, 9. Cameron, I. T., Haining, R., Lumsden, M. A., Thomas, V. R., & Smith, S. K. (1990). The effects of mefenamic acid and norethisterone on measured menstrual blood loss. Obstetrics and Gynecology, 76(1), 85–88. Chan, S. S., Tam, W. H., Yeo, W., et al. (2007). A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women. BJOG, 114(12), 1510–1515. Cramer, S. F., & Patel, A. (1990). The frequency of uterine leiomyomas. American Journal of Clinical Pathology, 94(4), 435–438. Critchley, H. O., Duncan, W. C., Brito-Mutunayagam, S., & Reynolds, R. M. (2013). Obesity and menstrual disorders. In T. A. Mahmood & S. Arulkumaran (Eds.), Obesity: A ticking time bomb for fertility (Elsevier Insights) (pp. 525–535). Elsevier. CRUK. Uterine Cancer Incidence Statistics: Uterine cancer incidence trends over time (last reviewed May 2014). DeWaay, D. J., Syrop, C. H., Nygaard, I. E., et al. (2002). Natural history of uterine polyps and leiomyomata. Obstetrics and Gynecology, 100(1), 3–7. Everett, J. W. (1994). Pituitary and hypothalamus: perspective and overview. In E. Knobil & J. D. Neill (Eds.), The physiology of reproduction (Vol. 1, 2nd ed., pp. 1509–1526). Raven Press. Foth, D., Röhl, F.-W., Friedrich, C., Tylkoski, H., Rabe, T., Römer, T., et al. (2017). Symptoms of uterine myomas: Data of an epidemiological study in Germany. Archives of Gynecology and Obstetrics, 295, 415–426. Fraser, I. S. (2007). The promise and reality of the intrauterine route for hormone delivery for prevention and therapy of gynecological disease. Contraception, 75(6 Suppl), S112–S117. Fraser, I. S., & Kovacs, G. T. (2003). The efficacy of non-contraceptive uses for hormonal contraceptives. The Medical Journal of Australia, 178(12), 621–623. Fraser, I. S., Mansour, D., Breymann, C., Hoffman, C., Mezzacasa, A., & Petraglia, F. (2015). Prevalence of heavy menstrual bleeding and experiences of affected women in a European patient survey. International Journal of Gynaecology and Obstetrics, 128, 196–200. Gleeson, N. C., Buggy, F., Sheppard, B. L., & Bonnar, J. (1994). The effect of tranexamic acid on measured menstrual loss and endometrial fibrinolytic enzymes in dysfunctional uterine bleeding. Acta Obstetricia et Gynecologica Scandinavica, 73(3), 274–277. Gong, E. J., Garrel, D., & Calloway, D. H. (1989). Menstrual cycle and voluntary food intake. The American Journal of Clinical Nutrition, 49, 252–258. Gupta, S., Jose, J., & Manyonda, I. (2008). Clinical presentation of fibroids. Best Practice & Research. Clinical Obstetrics & Gynaecology, 22, 615–626. Hallberg, L., & Nilsson, L. (1964). Determination of menstrual blood loss. Scandinavian Journal of Clinical and Laboratory Investigation, 16, 244–248. Hapangama, D. K., Kamal, A. M., & Bulmer, J. N. (2015). Estrogen receptor beta: The guardian of the endometrium. Human Reproduction Update, 21(2), 174–193. Hartmann, K. E., Fonnesbeck, C., Surawicz, T., Krishnaswami, S., Andrews, J. C., Wilson, J. E., et al. (2017). Management of uterine fibroids. Comparative effectiveness review no. 195. Agency for Healthcare Research and Quality. Hartz, A. J., Barboriak, P. N., Wong, A., Katayama, K. P., & Rimm, A. A. (1979). The association of obesity with infertility and related menstural abnormalities in women. International Journal of Obesity, 3(1), 57–73. Hickey, M., & Fraser, I. (2003). Human uterine vascular structures in normal and diseased states. Microscopy Research and Technique, 60(4), 377–389. Irvine, G. A., Campbell-Brown, M. B., Lumsden, M. A., Heikkila, A., Walker, J. J., & Cameron, I. T. (1998). Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. British Journal of Obstetrics and Gynaecology, 105(6), 592–598. Jabbour, H. N., Kelly, R. W., Fraser, H. M., & Critchley, H. O. (2006). Endocrine regulation of menstruation. Endocrine Reviews, 27(1), 17–46. Karlsson, T. S., Marions, L. B., & Edlund, M. G. (2014). Heavy menstrual bleeding significantly affects quality of life. Acta Obstetricia et Gynecologica Scandinavica, 93(1), 52–57. Kitawaki, J. (2006). Adenomyosis: The pathophysiology of an oestrogen-dependent disease. Best Practice & Research. Clinical Obstetrics & Gynaecology, 20(4), 493–502. Lethaby, A., Irvine, G., & Cameron, I. (2008). Cyclical progestogens for heavy menstrual bleeding. Cochrane Database of Systematic Reviews, 1, CD001016. Lethaby, A., Wise, M. R., Weterings, M. A., Bofill Rodriguez, M., & Brown, J. (2019). Combined hormonal contraceptives for heavy menstrual bleeding. Cochrane Database of Systematic Reviews, 2(2), CD000154. Li, F., Wei, S., Yang, S., et al. (2018). Post hysteroscopic progesterone hormone therapy in the treatment of endometrial polyps. Pakistan Journal of Medical Science, 34(5), 1267–1271. Longo, D. L., & Bulun, S. E. (2013). Uterine fibroids. The New England Journal of Medicine, 369, 1344–1355. Lyons, P. M., Truswell, A. S., Mira, M., Vizzard, J., & Abraham, S. F. (1989). Reduction of food intake in the ovulatory phase of the menstrual cycle. The American Journal of Clinical Nutrition, 49, 1164–1168. Meresman, G. F., Auge, L., Baranao, R. I., et al. (2002). Oral contraceptives suppress cell proliferation and enhance apoptosis of eutopic endometrial tissue from patients with endometriosis. Fertility and Sterility, 77(6), 1141–1147. Munro, M. G., et al. (2011). FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. International Journal of Gynaecology and Obstetrics, 113(1), 3–13. National Institute for Health and Care Excellence. (2018). Heavy menstrual bleeding: Assessment and management. National Institute for Health and Care Excellence. Oguz, S., Sargin, A., Kelekci, S., et al. (2005). The role of hormone replacement therapy in endometrial polyp formation. Maturitas, 50(3), 231–236. Peric, H., & Fraser, I. S. (2006). The symptomatology of adenomyosis. Best Practice & Research. Clinical Obstetrics & Gynaecology, 20(4), 547–555. Rowland, A. S., Baird, D. D., Long, S., et al. (2002). Influence of medical conditions and lifestyle factors on the menstrual cycle. Epidemiology, 13(6), 668–674. Royal College of Obstetricians and Gynaecologists. (2012). National menstrual heavy bleeding audit. Second Annual Report. Royal College of Obstetricians and Gynaecologists. www.rcog.org.uk Setiawan, V. W., Yang, H. P., Pike, M. C., et al. (2013). Type I and II endometrial cancers: have they different risk factors? Journal of Clinical Oncology, 31(20), 2607–2618. Sivridis, E., & Giatromanolaki, A. (2011). The pathogenesis of endometrial carcinomas at menopause: Facts and figures. Journal of Clinical Pathology, 64(7), 553–560. Speroff, L., & Fritz, M. A. (2005). Clinical gynecologic endocrinology and infertility. Lippincott Williams & Wilkins. Speroff, L., & Fritz, M. A. (Eds.). (2010). Clinical gynecologic endocrinology and infertility (8th ed.). Wolters Kluwer/Lippincott, Williams & Wilkins. Speroff, L., Fritz, M. A., & (eds). (2010). Clinical gynecologic endocrinology and infertility (8th ed.). Wolters Kluwer/Lippincott, Williams & Wilkins. Tarttelin, M. F., & Gorski, R. A. (1971). Variations in food and water intake in the normal and acyclic female rat. Physiology & Behavior, 7, 847–852. ter Haar, M. B. (1972). Circadian and estrual rhythms in food intake in the rat. Hormones and Behavior, 3, 213–219. Treloar, A. E., Boynton, R. E., Behn, B. G., & Brown, B. W. (1967). Variation of the human menstrual cycle through reproductive life. International Journal of Fertility, 12(1 Pt 2), 77–126. Van Voorhis, B. (2009). A 41-year-old woman with menorrhagia, anemia, and fibroids: Review of treatment of uterine fibroids. JAMA, 301(1), 82–93. Vercellini, P., Vigano, P., Somigliana, E., Daguati, R., Abbiati, A., & Fedele, L. (2006). Adenomyosis: Epidemiological factors. Best Practice & Research. Clinical Obstetrics & Gynaecology, 20(4), 465–477. Warner, P. E., Critchley, H. O., Lumsden, M. A., Campbell-Brown, M., Douglas, A., & Murray, G. D. (2004). Menorrhagia I: Measured blood loss, clinical features, and outcome in women with heavy periods: A survey with follow-up data. American Journal of Obstetrics and Gynecology, 190(5), 1216–1223. Yen, S. S. C., Jaffee, R. B., & Barbieri, R. L. (1999). Reproductive endocrinology: Physiology, pathophysiology and clinical management. W.B. Saunders Company. Author information Authors and Affiliations Corresponding author Editor information Editors and Affiliations Section Editor information Rights and permissions Copyright information © 2023 Springer Nature Switzerland AG About this entry Cite this entry Kumar, N., Jha, N.K., Singh, I.K., Jha, S.K., Jha, A.K. (2023). Estradiol-Progesterone Balance Paradigm: Heavy Menstrual Flow. In: Shackelford, T.K. (eds) Encyclopedia of Sexual Psychology and Behavior. Springer, Cham. https://doi.org/10.1007/978-3-031-08956-5_867-1 Download citation DOI: https://doi.org/10.1007/978-3-031-08956-5_867-1 Received: Accepted: Published: Publisher Name: Springer, Cham Print ISBN: 978-3-031-08956-5 Online ISBN: 978-3-031-08956-5 eBook Packages: Living Reference Behavioral Science and PsychologyReference Module Humanities and Social SciencesReference Module Business, Economics and Social Sciences